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Abstract 
Alphaviruses are positive strand RNA viruses that replicate in association with 
cellular membranes. The viral RNA replication complex consists of four non-
structural proteins nsP1-nsP4 which are essential for viral replication. The functions 
of nsP1, nsP2 and nsP4 are well established, but the roles of nsP3 are mainly 
unknown. In this work I have clarified some of the functions of nsP3 in order to 
better understand the importance of this protein in virus replication. Semliki Forest 
virus (SFV) has been mostly used as a model alphavirus during this work, but some 
experiments have also been conducted with Sindbis and Chikungunya viruses. 
NsP3 is composed of three different protein domains. The N-terminus of nsP3 
contains an evolutionarily conserved macrodomain, the central part of nsP3 contains 
a domain that is only found in alphaviruses, and the C-terminus of the protein is 
hypervariable and predicted to be unstructured. In this work I have analyzed the 
functions of nsP3 macrodomain, and shown that viral macrodomains bind poly(ADP-
ribose) and that they do not resemble cellular macrodomains in their properties. 
Furthermore, I have shown that some macrodomains, including viral macrodomains 
of SFV and hepatitis E virus, also bind poly(A). Mutations in the ligand binding 
pocket of SFV macrodomain hamper virus replication but do not confer lethality, 
indicating that macrodomain function is beneficial but not mandatory for virus 
replication. 
The hypervariable C-terminus of nsP3 is heavily phosphorylated and is 
enriched in proline residues. In this work I have shown that this region harbors an 
SH3 domain binding motif (Sh3BM) “PxRxPR” through which cellular amphiphysin 
is recruited to viral replication sites and to nsP3 containing cytoplasmic aggregate 
structures. The function of Sh3BM was destroyed by a single point mutation, which 
led to impaired viral RNA replication in HeLa cells, pointing out the functional 
importance of amphiphysin recruitment by the Sh3BM. In addition, I have provided 
evidence that the endosomal localization of alphavirus replication is mediated by 
nsP3 and that the phosphorylation of hypervariable region might be important for the 
endosomal targeting. 
Together these findings demonstrate that nsP3 contains multiple important host 
interaction motifs and domains, which facilitate successful viral propagation in host 
cells. 
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1 Introduction 
1.1 Positive‐strand RNA viruses 
Viruses are small infectious agents that replicate only inside living cells. They are 
found everywhere in nature, and they infect organisms from all kingdoms of life. 
Viruses are classified into six different groups, based on the type of their genetic 
material. Viral genome can be composed of either DNA or RNA, and it can be either 
single or double stranded. The largest group of viruses under this classification is 
positive-strand RNA viruses. The genome of these viruses consists of RNA that is of 
the same sense as host cell mRNA and can be directly translated to viral proteins by 
host cell machinery. The RNA genome can consist of a single RNA molecule, or 
several different RNA molecules that are all needed for viral replication. 
Positive-strand RNA viruses include several human pathogens such as 
poliovirus, severe acute respiratory syndrome coronavirus (SARS-CoV), Rubella virus 
and Hepatitis A, C and E viruses (HAV, HCV, HEV). Positive-strand RNA viruses do 
not have a DNA intermediate in their replication cycle, but maintain their genome 
purely in an RNA form. The replication of the genome is achieved by viral replication 
proteins, among which is an RNA dependent RNA polymerase (RdRp) that is able to 
synthesize RNA from an RNA template. The whole replication cycle takes place in the 
cytoplasm, where positive-strand RNA viruses form membrane-bound replication 
complexes that are typically surrounded by virus-modified host membranes (160). 
These membranous structures are thought to concentrate the virus replication factors 
to the sites of replication and to protect the viral RNA from host cell defence 
mechanisms (145). 
1.2 Alphaviruses 
Alphaviruses are small enveloped positive-strand RNA viruses belonging to the family 
Togaviridae. The only other member of Togaviridae is Rubella virus, the sole member 
of genus Rubivirus. Alphaviruses are animal viruses that infect various vertebrate 
hosts. The genus contains at least 24 species of which many can also infect humans 
(132). They are transmitted mainly via mosquito vector, in which they cause systemic 
infection but no symptomatic disease. Thus alphaviruses are often referred to as 
arthropod borne viruses (arboviruses), although currently it is uncertain whether 
salmonid alphaviruses are transmitted through lice or can be directly transmitted from 
fish to fish (128, 140).  
Alphaviruses can be divided into two categories based on the geographic area 
where they spread: Old World and New World viruses. Diseases caused by 
alphaviruses partially follow the geographical distribution, as many Old World viruses 
cause a disease characterized by rash and high fever and sometimes painful arthralgia, 
whereas several New World viruses cause encephalitis. However, there are close 
genetic relationships between Old World and New World alphaviruses, which 
probably originate from several transoceanic exchanges mediated by birds (132). 
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The best characterized alphaviruses are Semliki Forest virus (SFV) and Sindbis 
virus (SINV). These viruses are the representatives of two of the main alphavirus 
groups, namely the SFV complex and western equine encephalitis virus (WEEV) 
complex. They are considered rather safe for laboratory use, since SFV the typical 
strains of SFV do not cause a disease in humans in nature, and SINV causes a rather 
mild illness characterized by fever and rash. The third main group of alphaviruses is 
the Eastern equine encephalitis virus (EEEV) / Venezuelan equine encephalitis virus 
(VEEV) –complex (132, 161). All the three equine encephalitis viruses reside in the 
New World and cause a devastating neuronal disease in horses, with occasional 
outbreaks in humans with high mortality rates (159). Other alphaviruses may also 
harbour potential for neuropathogenicity. For example, an untypical strain variant of 
SFV, named Me Tri virus, was associated with encephalitis in children in Vietnam in 
the early 1970s, and the laboratory strain of SFV has caused a rare case of encephalitis 
in an immunosuppressed person (66, 103, 164). Arthritogenic alphaviruses may also 
cause very difficult symptoms, as is the case with Chikungunya virus (CHIKV), a 
member of SFV complex, that has caused several outbreaks in Africa, Asia and 
Europe since year 2005 (138, 167).  
Chikungunya gets its name from the Kimakonde language of Tanzania and 
Mozambique and translates in Swahili to “the illness of the bended walker”. It causes 
a severe fever illness named “Chikungunya fever” (CHIKF). About 95% of the 
humans that are infected get a symptomatic disease. Acute phase CHIKF symptoms 
include fever, arthralgia, and in some cases, rash (137). The acute phase inflicts 
intense joint and muscular pain that causes severe suffering and prostrates its victims. 
About 40% of patients get a chronic chickungunya arthritis that persists more than 18 
months after the onset of the fever. Old people are especially susceptible to CHIKF, 
and the disease is lethal in about 33 % of victims over 65 years of age (reviewed in 
(167)).  
To date there is no existing vaccine or treatment against alphaviruses, which 
drives interest in alphavirus research. Another important line of alphavirus work is the 
development of viral vectors. Currently, these vectors can be used in laboratory as a 
tool for efficient production of recombinant proteins, but the ultimate goal is to 
develop vectors for use in gene therapy and anti-cancer treatment (99, 100, 136). My 
personal interest in alphavirus research lies in the understanding of basic molecular 
and biological mechanisms behind the interactions between virus and the host cell. 
This line of research is gaining growing amount of attention, as it becomes evident 
that many cellular factors play important roles in positive-strand RNA virus 
replication.  
1.3 Alphavirus life cycle 
1.3.1 Virus entry 
Alphaviruses enter the cell via clathrin-mediated endocytosis. The entry is mediated 
by two viral spike glycoproteins: the entry protein E2 and the fusion protein E1. The 
entry begins with interaction between the immunoglobulin-like domains of the spike 
protein E2 and a specific cell surface receptor (97, 181). It is not known, which 
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receptors are recognized by alphaviruses in nature, but many laboratory strains have 
adapted to use heparan sulphate as a receptor, and lectins have been suggested as a 
possible target upon primary alphavirus infection in animals (85).  
Virions that are bound to a receptor are endocytosed in a clathrin-dependent 
manner, and end up in endocytic vesicles (72). Upon acidification of the endosome, 
domain B of E2 is released from the fusion loop in E1,which makes the fusion loop 
exposed (Figure 1A). This triggers a conformational change in the viral spike hetero-
dimer leading to escape of E2 protein and trimerization of E1. This causes the fusion 
of viral envelope and endosome membrane through a mechanism that involves large 
conformational changes in viral glycoproteins, and the virus capsid is released into the 
cytoplasm (Fig. 1A) (97, 181). In the cytoplasm, the unenveloped capsid is 
disassembled, probably trough an interaction with a ribosome, and viral RNA is 
released (183). The viral genome is then translated into viral replication proteins, and 
the viral RNA is replicated as will be explained in more detail below. Finally capsid 
and envelope proteins are produced as a single polypeptide that is subsequently 
cleaved by host and viral proteases into the structural proteins needed for virus particle 
formation and assembly (Fig. 1B) (77).  
1.3.1 RNA replication 
Alphavirus genome consists of a single ~11.5 kb RNA molecule, which contains a cap 
structure and a polyadenylate (poly(A)) tail. The genome encodes four non-structural 
proteins (nsP1-4) and five proteins needed for formation and assembly of the virus 
particle (E1, E2, E3, 6K and capsid). During alphavirus replication three different 
types of RNA are produced. Initially a minus strand (42S RNA in SFV) is produced 
from the viral genome. The minus strand serves as a template for synthesis of new plus 
strand genomes (42S RNA) needed for virus assembly, and for shorter mRNAs (26S 
RNA) from which the structural proteins are translated (78, 160). 
Viral replication proteins are initially translated as a single polypeptide P1234. 
The polypeptide is cleaved into viral replication proteins nsP1-4 by a protease domain 
in nsP2 that recognizes conserved cleavage sites between the nsPs. The protease 
moiety, when inside the polypeptide, is able to cleave efficiently only the 3/4 site in 
cis. The termini of nsP2 (1/2 and 2/3 sites) can be efficiently cleaved only in trans. 
Consequently, the early replication complex consists of P123 and nsP4 (112, 176). 
This complex produces the negative strand RNA, and can also produce positive-strand 
genomic RNA, but not subgenomic RNA. Conformational changes are needed to form 
the late replicase that produces the genomic and subgenomic RNA, but is no more able 
to produce negative strand RNA. Polyprotein processing by nsP2 facilitates these 
conformational changes in the replication complex, and the fully processed replication 
proteins (nsP1-nsP4) form the late replicase (93, 150, 176). This leads to temporal 
regulation of viral RNA replication, so that early in the infection negative strands are 
produced as new replication complexes form. One replication complex probably 
produces only one negative strand RNA, to be used as a template in positive strand 
RNA synthesis. The early replication complex can then produce new genomic RNAs 
for synthesis of nsPs, leading to formation of new replication complexes. When the 
replication complex matures through in trans cleavages, it can recognize the promoter 
for subgenomic RNA, needed for production of structural proteins, but it maintains 
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capability of produce also full length genomic RNA. Late in the infection no new 
replication complexes are formed, probably partially due to efficient cleaving at 2/3 
site, which produces P34 that is incapable of forming active replicase. At the late 
stage, structural proteins are produced very efficiently and genomic RNAs are 
synthesized for production of new viruses (reviewed in (78, 160)). 
 
 
A 
B 
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Figure  1. Alphavirus replication cycle. (A) Structural changes in viral glycoproteins 
during the virus entry. Domain B (B) of E2 (blue) is unattached from E1 (orange-
green) and the fusion loop (Ã) becomes exposed. This leads to disassembly of viral 
spike and homotrimers of E1 are formed. The model is redrawn based on ref. (97) (B) 
Alphavirus replication cycle is achieved in the cytoplasm. Incoming RNA is translated 
into four non-structural proteins which transcribe the viral RNA. RNA transcription 
and viral protein processing are shown in the left bottom corner. Glycoproteins are 
further modified in endoplasmic reticulum (ER) and Golgi as shown on the right side. 
Virus budding appears at the plasma membrane (PM). Reproduced with permission 
from ref (77). 
1.4 Alphavirus RNA replication machinery 
Alphavirus replicase consists of four nsPs. The functions and enzymatic activities of 
these proteins have been well established, except for nsP3, the function of which is 
still quite poorly understood. All nsPs are needed for formation of functional 
replication complex. In addition, each replication protein is present in cell as an 
independent protein that may have important functions other than those directly linked 
to RNA replication. 
1.4.1 nsP1 
NsP1 is the protein responsible for the membrane association of the replication 
complex (125, 146). An amphipathic alpha helix in the central part of the protein is 
responsible for this membrane association, but palmitoylation of a distant site is 
needed for tight membrane binding (4, 158) In addition, nsP1 is the viral capping 
enzyme possessing methyltransferase and guanylyltransferase activities (3, 114). To 
initiate the capping reaction, the RNA triphosphatase activity of nsP2 is also needed. 
Formation of the 7-methyl-guanine-cap is achieved in a different way as compared to 
eukaryote cells, since GTP is first methylated and only after that transferred to the 
RNA, not vice versa (3). 
NsP1 molecules that are not part of replication complex localize to plasma 
membrane. When overexpressed by transfection, nsP1 causes the formation of 
filopodia-like protrusions that are devoid of actin filaments (89). In virus infected cells 
similar structures are seen layered with nsP1 at the inner side of the membrane, but 
these structures are typically larger and contain actin. Also viral RNA has been 
detected inside the protrusions (155). It has been proposed that these filopodia-like 
structures might make connections to neighbouring cells to enable virus RNA to 
spread in a budding independent manner, similar to what has been recently shown for 
Rubella virus (107, 155).  
1.4.2 nsP2 
NsP2 is the protease responsible for processing of the viral replication proteins. The 
protease domain in the C-terminus is homologous to papain-like cysteine proteinases 
(13, 60). It has been proposed that the proteolytic cleavage of the polyprotein is the 
key temporal regulator of viral RNA replication, which controls the promoter 
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recognition by the viral RNA replicase (93, 176). NsP2 possesses several enzymatic 
activities in addition to protease activity, namely helicase activity, nucleoside 
triphosphatase (NTPase) activity and RNA triphosphatase activity. NsP2 helicase is 
able to unwind partially double-stranded RNA, and the NTPase hydrolysis by the 
same protein seems to be a driving force for the unwinding (61, 139). RNA 
triphosphatase activity of nsP2 is needed for removing the gamma-phosphate from the 
nascent RNA before the cap-structure can be added by nsP1 (175).  
Several mutations in nsP2 have been reported to have an effect on negative 
strand RNA synthesis and sub-genomic RNA synthesis (37, 162). Some, but not all of 
these mutational effects, can be explained by the fact that they map to nsP2 C-
terminus, and affect nsP2 protease domain and polyprotein processing. Some 
mutational effects may be explained by the fact that early in the infection nsP2 
functions in the form of P23 (or P123) to be able to form active negative strand 
replicase, and many determinants can affect the folding and stability of the precursor 
protein (36, 37, 149, 162). It has been also suggested that nsP2 – host cell interactions 
might be important for minus-strand synthesis cessation (149). 
When cleaved from the polyprotein, a portion of nsP2 that is not bound to 
replication complex is transported to nucleus. In SFV the transport is mediated by a 
nuclear localization signal (NLS) that consists of a PRRRV sequence in the C-
terminus of the protein and other determinants in distinct loci (139). NsP2 of Old 
World viruses SFV and SINV inhibits cellular transcription in nucleus by a yet 
unknown mechanism (55, 56). However, nsP2 protein of New World viruses VEEV 
and EEEV does not cause transcription inhibition, but instead the inhibition seems to 
be mediated by the capsid protein (56). NsP2 also suppresses the interferon response 
of the host cell, and interestingly this function has been shown to be independent of 
transcription shut off, but seems to be mediated by specific inhibition of Jak/Stat 
(Janus kinase/signal transducers and activators of transcription) signaling (50, 152). 
1.4.3 nsP3 
In contrast to other nsPs, no enzymatic function in RNA replication has been shown 
for nsP3. However, nsP3 is needed for RNA replication, and mutations in nsP3 have 
been shown to affect negative strand RNA synthesis and subgenomic RNA synthesis 
(68, 91). Similar defects in RNA synthesis have been detected with mutations in nsP2 
or with the mutations either inactivating or hyperactivating 2/3 site cleavage (37, 93, 
104), indicating that interactions between nsP3 and nsP2 might be important for the 
correct formation of the replication complex. The 2/3 site cleavage has been shown to 
be the most important factor for switching off the negative strand RNA synthesis (83, 
93). Thus, nsP3 might function in RNA replication together with nsP2 as a structural 
component responsible for the conformational changes in the replicase, rather than 
have a direct enzymatic function on the RNA. However, there is growing evidence for 
the role of nsP3 in virus-host interaction, which will be discussed in a separate chapter 
below. 
1.4.4 nsP4 
NsP4 is the catalytic subunit of the RNA polymerase in the alphavirus replication 
complex. The catalytic core of the enzyme contains a conserved GDD motif that is 
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found in many viral RdRps (80, 86). The N-terminus of alphavirus nsP4 contains a 
short non-conserved region that has no similarities with other viral polymerases. This 
region is probably needed for interaction with other nsPs and viral RNA. The cleavage 
of nsP4, which exposes the N-terminus, is a prerequisite for functional polymerase, 
and it has been shown that an aromatic residue in the N-terminus is needed for 
alphavirus replication in vivo (93).  NsP4  has  also  been  shown  in vitro to contain 
adenylyl transferase activity, which may help to maintain the poly(A) tail of viral 
positive-sense RNAs (170). 
Some alphaviruses like SFV produce nsP4 in equimolar amounts with other 
nsPs, whereas other viruses like SINV contain an opal termination codon between 
nsP3 and nsP4. The opal codon in SINV is read through with about 10% efficiency, so 
that only a minority of non-structural polyproteins contain nsP4 (95). Unlike other 
nsPs, nsP4 is not known to have independent functions when not bound to replication 
complex, and nsP4 is efficiently degraded in the N-end rule dependent manner, when 
released into cytoplasm (35). 
1.4.5 Membrane-bound replication complex 
Membrane association mediated by nsP1 is essential for the formation of the 
replication complex, and viral RNA replication correlates with the emergence of 
spherical membrane invaginations (“spherules”) intimately associated with viral 
proteins (47, 51, 65, 87) (Fig. 2). Consequently, the viral RNA replication is thought to 
occur inside of the spherules. How the spherules and the associated viral replication 
complex are formed, is not exactly known, but membrane binding seems to be an 
absolute prerequisite for RNA replication, and both the viral nsPs and RNA replication 
have been shown to be needed for spherule formation (157, 158). It is not known, 
whether some host protein components are also needed for replication complex 
assembly and spherule formation. However, several host proteins have been shown to 
be associated with viral proteins in SINV infected cells (29, 48). In the case of Brome 
mosaic virus, a positive-strand RNA virus classified into the “Alphavirus-like 
superfamily”, a membrane shaping host reticulon protein has been shown to be 
necessary for spherule formation (39). 
Alphavirus replication complexes first form at the plasma membrane, where the 
polyprotein P1234 is targeted by nsP1 (145, 146). NsP1 can adopt its active fold only 
when associated to a lipid layer (5). Consequently, replication complexes can only 
form in association with cellular membranes. RNA binding is also thought to be 
needed for correct formation of replication complexes, and the spherules can not be 
formed in the absence of viral RNA replication (156). However, replication complexes 
remain on the plasma membrane only for a short period (157). They are targeted from 
there to virus induced endo-lysosomal organelles, named cytopathic vacuoles type I 
(CPVs), where the alphavirus replication is thought to mainly occur (87, 157). It is not 
known, how the replication complexes are targeted to endosomes, although the 
transport has been shown to depend on actin and microtubules (157).  
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Figure 2. Alphavirus spherules imaged with electron microscopy. (A) Spherules are 
detected inside of endocytic vesicles labeled with gold-bovine serum albumin (BSA). 
(B) Side view of spherules detected at the plasma membrane show the connection 
between spherule and the cytoplasm through narrow neck. Bars 200 nm. Reproduced 
with permission from reference (87). 
1.5 Host interaction protein nsP3 
In alphavirus infected cells, nsP3, like all the nsPs (with the possible exception of 
nsP4), is present in the cytoplasm in two different pools (78). NsP3 can be detected in 
spherules as a part of the replication complex, and secondly nsP3, when not associated 
with replication complex, forms aggregates in the cytoplasm (29, 146). Several 
cellular proteins including heat shock protein 90, Ras-GAP SH3 domain binding 
protein (G3BP), and tubulin have been found to associate with nsP3 in SINV infected 
cells (29, 48). Several of these proteins colocalize with nsP3 aggregates when 
observed by immunofluorescence (29, 48, 63). Many of the proteins found in nsP3 
aggregates are probably also present in replication complexes as has been confirmed 
by colocalization and co-immunoprecipitation of these proteins with the viral RdRp 
nsP4 (30). Based on these recent findings, it seems likely that nsP3 is interacting with 
several host proteins. However, none of these studies proved a direct binding between 
a host protein and nsP3, and thus some of the detected nsP3 – host protein interactions 
might actually be mediated by other nsPs, associated cellular proteins or viral RNA. 
NsP3 can be divided into three different domains based on the conservation of 
these parts (Fig. 3). The N-terminus of nsP3 consists of a macrodomain that is a 
globular domain, which has been highly conserved in evolution. The central part of 
nsP3 consists of a sequence that is conserved between alphaviruses but has no 
sequence similarity with any of the known protein domains from other organisms (78). 
Consequently, this domain is here termed alphavirus unique domain (AUD). In 
contrast to the first two domains, the C-terminus of nsP3 has no sequence similarity 
even amongst alphaviruses and has been termed the hypervariable region (HVR). 
As many alphaviruses can cause a severe brain disease, several studies have 
aimed to specify the neurovirulence determinants of SFV and SINV. Many of the 
amino acids contributing to neurovirulence have been found to reside in nsP3, 
indicating that nsP3 might be an important pathogenicity factor in alphavirus infected 
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cells (122, 163, 172). Interestingly, mutations attenuating the neurovirulence can be 
found in each of the three domains in nsP3, and also an opal termination codon in the 
3/4 junction causes attenuation (163, 172, 173). One study showed that deletions in 
SFV HVR cause attenuation of the virus after peripheral inoculation, indicating that 
pathogenicity factors inside nsP3 are not just neuron specific (53). 
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Figure 3. Alphavirus nsP3. N-terminus of nsP3 consists of a globular macrodomain. 
Central ~160 amino acids form an alphavirus unique domain (AUD) of unknown 
function. AUD mutants displaying replication defects are depicted in picture in 
relative positions compared to each other. Mutations in SFV are shown in blue and in 
SINV in black. C-terminal hypervariable region is characterized by presence of 
phosphorylation site (black balls with “P”) and proline rich region (PxRxPR). 
Mutations are depicted with the names given in the original publications (36, 91, 172). 
 
1.5.1 Macrodomain 
The N-terminus of alphavirus nsP3 comprises an evolutionarily conserved domain of 
~170 amino acids (aa), initially termed “the X domain” for its unknown function in 
viral replication (62). In addition to alphaviruses, Rubella virus, HEV (the sole 
member of the genus Hepevirus), and corona and toroviruses in the family of 
Coronaviridae are the only other virus genera known to contain an X-domain. Similar 
domains sharing the fold of the viral X-domains are found in all the kingdoms of life 
in various different proteins. Probably the best studied of these is an atypically large 
histone termed “macrohistone” that is found only in vertebrates (reviewed in (168)). 
The non-histone domain of the protein was termed macrodomain, and therefore all the 
conserved domains sharing the same fold, including X-domains, have been termed 
macrodomains (123). The macrodomains from different organisms are further 
discussed in chapter 1.6. 
The first hint of the macrodomain function came from a yeast protein library 
screen. A macrodomain from yeast was shown to be able to hydrolyse 
adenosinediphospho-ribose1''phospahate (ADPR1-P), a by-product from yeast t-RNA 
splicing, indicating an enzymatic function for a macrodomain (151). This was the first 
indication that nsP3 might have an enzymatic function through one of its domains. In 
another study, several macrodomains were shown to bind ADP-ribose (ADPR), and it 
was suggested that macrodomains are ADPR binding moieties in general (81). These 
findings could explain the macrodomain conservation in alphaviruses, whether the 
reason is an enzymatic activity or ADPR binding. In addition to the putative ADPR-
related activity of macrodomain, macrodomain may be important for alphavirus 
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replication also for another reason. When the processing of P1234 polypeptide by viral 
protease nsP2 was studied with artificial substrates containing short stretches (~40 aa) 
from each cleavage site, the cleavage of 2/3 site was not detected (177). However, 
when the whole macro domain (170 aa) was included in the nsP3 side, nsP2 was able 
to cleave the substrate (59, 177). Thus it seems that the properly folded macrodomain 
is needed for correct polyprotein processing in alphaviruses. 
1.5.2 Alphavirus unique domain (AUD) 
Very little is known of the functions of AUD, which is a ~160 aa protein region in the 
central part of nsP3. This domain is conserved in alphaviruses, as can be seen from the 
sequence homology, but its structure is unknown, and there are no similar proteins in 
other organisms based on the protein sequence. However, several computational 
programs predict that at least the C-terminal part of AUD is most likely folded and 
consequently forms a three dimensional structure (PredictProtein server (142)).  
Several mutations that affect viral RNA synthesis and neurovirulence of the 
virus map to AUD (Fig. 3). These include SINV mutants CR3.34, CR3.39, ts4 and 
ts7B5 and SFV mutants F201L and N249D (36, 91, 172). Some of the mutants have a 
defect in subgenomic RNA synthesis (CR3.34), whereas others are incapable of 
producing negative strand RNA at 40 °C (CR3.39, ts4) or have impaired polyprotein 
processing (ts7B5) (36, 91, 172). Interestingly CR39.9 and ts4 were also defective in 
phosphorylation of the HVR at 40 °C, indicating that there is an interplay between 
AUD and HVR (36). Point mutations F201L and N249D in SFV have been shown to 
reduce the neurovirulence of the virus when introduced peritoneally into mice, but the 
mechanism of the reduction is unknown (172).  
1.5.3 Hypervariable region (HVR) 
The boundary between AUD and HVR is not very exactly defined. Conserved region 
in SINV has been estimated to extend up to aa 324 in SINV (325 in SFV), and nsP3 is 
predicted to be highly unstructured in C-terminus beginning from the amino acid 312 
in SFV (91, 142). The HVR of nsP3 is variable in length and amino acid sequence 
amongst different alphaviruses. The size of HVR varies between ~150-250 aa, and it 
has been shown to tolerate large deletions when virus is replicated in cell culture (90, 
178). However, some similarities exist among the HVR of different alphaviruses; the 
region is rich in acidic residues, as well as in serine, threonine, and proline, and it 
doesn’t have predicted secondary structure ((178) and references therein). HVRs of 
SINV and SFV are known to be heavily phosphorylated, and nsP3 is the only 
alphavirus nsP modified by phosphorylation (96, 178). 
NsP3 proteins from SFV and SINV are phosphorylated on serine and threonine 
residues, but not on tyrosines (96, 127, 180). The phosphorylation sites of SFV are 
located in the beginning of HVR, and all detectable phosphorylation has been found to 
be inside of a 50 aa region (aa 319-368), where altogether 11-16 threonines and 
serines are phosphorylated (180). It has been shown that serine residues are more 
heavily phosphorylated than threonine residues (SFV) and that serines become first 
phosphorylated (SINV) (96, 127, 178). In SFV two adjacent threonines (T344 and 345 
in nsP3) and one serine (S320) were detected as the main sites responsible for 
phosphorylation. Point mutation of either of the threonines (T344/345A) or S320 
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reduced the phosphorylation of nsP3 by 40-50 % when expressed in HeLa cells (178). 
However, combination of these mutations did not further decrease the 
phosphorylation, which could indicate that these amino acids have a regulatory role in 
nsP3 phosphorylation, rather than being the main recipients of phosphorus groups 
themselves. (178). Interestingly, the serine 320 was not phosphorylated in a construct 
in which the C-terminus was deleted after aa 328, highlighting the importance of the 
interplay between different phosphorylation sites (178). 
Phosphorylation can modulate biological properties of proteins, such as protein 
stability, enzymatic activity, subcellular localization, or protein-protein interactions 
(reviewed in (26)). The functions of nsP3 phosphorylation are difficult to address 
because of the complicated nature of extensive phosphorylation. However, it has been 
shown that when phosphorylation is removed by a deletion of the whole 
phosphorylated region in SFV nsP3 (D319-368; virus mutant “D50”), viral RNA 
synthesis is reduced by about 50 % compared to wild type (wt) virus. Interestingly, 
this mutant virus replicates close to wt titres in cell culture, but is apathogenic in mice 
(178). Recently it was found that phosphorylation deficient SFV D50 does not form 
CPVs, but instead the spherules are detected on the plasma membrane throughout 
infection. This could indicate that the heavily phosphorylated 50 aa region might be 
linked to signaling that leads to the internalization of the replication complexes from 
the plasma membrane (10). 
The abundance of serines and threonines in nsP3 HVR seems to be explained by 
their use for phosphorylation, but the proline rich regions present in the HVR of 
alphaviruses have not been studied until now. Alphaviruses contain 1-3 proline rich 
regions, conjoined with an arginine residue, in the C-terminus of nsP3. These regions 
highly resemble an SRC homology 3 domain binding motif (Sh3BM) that is typically 
defined by presence of prolines and arginines, and can be defined in its most simplistic 
form as a PxxP motif (108). In this thesis, data is presented to show that the proline 
clusters in alphaviruses are functional SRC homology 3 (SH3) domain interaction 
motifs, which bind amphiphysin, and that this function is important for viral 
replication. 
NsP3 may contain yet other functional elements in addition to phosphorylation 
region and putative Sh3BMs. One such element could be FxxF sequence that is found 
in the very C-terminus of practically all the alphaviruses. FxxF motif containing 
region (nt 5637-5667; VITREEFEAF) was found to be the only region in VEEV HVR, 
which was intolerant to insertions (15). Based on the conservation of the motif and its 
intolerance to mutations, it would be tempting to hypothesize that this phenylalanine 
containing region is a functional motif important for alphavirus replication and 
therefore intolerant to mutations.  
1.6 The conserved macrodomain family 
Macrodomains constitute an evolutionarily conserved family of globular protein 
domains, which share a three layer α/β/α-fold with a twisted β-sheet surrounded by 4-6 
α-helices, and show a limited homology to P-loop nucleotide hydrolases (Fig. 4) (6). 
Currently, there are 791 proteins in the SMART database with a recognized 
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macrodomain fold (termed A1pp domain in SMART) (94). Macrodomains are found 
in all kingdoms of life as well as in some viruses, and they are highly conserved (94). 
The sequence identity of for example Escherichia coli macrodomain (YmdB) and a 
human macrodomain (MDO1) is 47 % at the protein level. However, not all the 
macrodomains share that high sequence identity, but certain highly conserved amino 
acid regions can be typically detected (see fig. 6). These highly conserved amino acids 
constitute a positively charged ligand binding pocket on the surface of the domain (I), 
(42, 81, 88). 
It has been shown in this work and by others that macrodomains bind through 
the ligand binding pocket various NAD+ metabolites like ADPR, o-acetyl-ADPR and 
poly(ADPribose) (PAR) (I, II), (42, 81, 88, 118). There is strong evidence that certain 
conserved amino acids in the binding pocket are essential for the specific ligand 
binding (see: Chapter 4: Results).  
 
Figure 4. CHIKV macrodomain. X-ray 
crystallography structure of CHIKV 
macrodomain shows the conserved α/β/α-
fold of macrodomains. Structure is colored 
by secondary structure succession (blue: N 
terminus), and the secondary structure 
element numbering is shown. Reproduced 
from ref. (105).  
 
 
 
 
 
 
1.6.1 Human macrodomain proteins 
The human genome contains at least 10 genes encoding macrodomains (75). 
Evolutionary relationships of human macrodomains are shown in figure 5. The most 
well known of the macrodomain proteins are the macrohistones. There are three 
different macrohistones in humans: macrohistone 2A1.1 (mH2A1.1) and mH2A1.2 are 
splice variants from the same gene, and mH2A2 is encoded by another gene located in 
a different chromosome (28). Macrohistones are atypically large histones, consisting 
of an N-terminal histone domain and an additional C-terminal macrodomain (123). 
The mH2A was first detected in inactive X-chromosomes where it is enriched, but it is 
also found in other subnuclear loci, especially associated with centrosomal 
heterochromatin (reviewed in (168)). There is growing evidence that the distribution 
of mH2A variants is linked to their ability to bind PAR. Recent data shows that the 
splicing variant mH2A1.1, capable of biding PAR, is transiently activated by poly-
ADPR polymerase-1 (PARP-1) mediated PARylation upon DNA damage, leading to 
localization of mH2A1.1 into damage sites, which causes chromatin compaction and 
Ku70-Ku80 heterodimer recruitment (169). Activation was mediated by PAR binding 
3
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through macrodomain, as confirmed by a macrodomain mutant (G224E), in which 
disruption of ADPR binding pocked led to incapability of sensing the PARP-1 
activation (169). In contrast to mH2A1.1, the splicing variant mH2A1.2 does not bind 
PAR and does not sense PARP-1 activation. MH2A1.1 is only detected in postmitotic 
and senescent cells, whereas mH2A1.2 is ubiquitously expressed (169). Another 
nuclear macrodomain protein, Alc1, was shown in two independent studies to be 
recruited by PARP-1 mediated PARylation to specific areas of chromatin, where it 
participates in chromatin relaxation through its Snf2-like domain (Snf = Sucrose Non 
Fermentation) (2, 64).  
 
Figure 5. Evolutionary relationships of human macrodomains. Evolutionary tree of 
human macrodomains including MDO1-3 is shown. MDO1, MDO2 and MDO3 form a 
cluster based on their evolutionary conservation. All currently recognized human 
macrodomains except Alc1 and C6orf130 are included in the evolutionary tree. 
Several macrodomains from the same PARP protein are numbered beginning from the 
N-terminus. Modified from reference (1). 
 
Many macrodomains have been shown to bind PAR, and interestingly, three 
human macrodomain proteins (PARP9, PARP14 and PARP15) also contain a PARP 
domain (I, II), (1, 81). These proteins, formerly known as BAL1-3 (B-Aggressive 
Lymphoma proteins 1-3), contain two to three N-terminal macrodomains and one C-
terminal PARP domain. It has been shown that macrodomain containing PARPs are 
able to PARylate themselves through activation of their PARP domains in a DNA 
dependent manner (1). In addition, PAR binding by PARP-9 macrodomains has been 
verified in vitro (81), and PARP-14 has been shown to function as a transcriptional 
regulator of interleukin-4 mediated Stat6 signalling in vivo, in a PARylation dependent 
manner (23, 109). Consequently, macrodomain containing PARPs are unique proteins, 
in that can both synthesize and bind PAR. 
Most of the human macrodomain proteins seem to localize in the nucleus and 
have been shown to function in the regulation of chromatin structure and 
transcriptional activation/repression (1, 2, 64, 70, 169). I was interested to study 
human macrodomain proteins that might reside in cytoplasm similar to viral 
macrodomain proteins. Potential candidates for cytoplasmic macrodomain proteins 
could be macro domain protein 1 (MDO1/ leukemia related protein 16; LRP16), 
macrodomain protein 2 (MDO2), ganglioside induced differentiation-associated 
protein 2 (GDAP2/ macro domain protein 3; MDO3) and C6orf130 (Chromosome 6 
open reading frame 130) protein. MDO2 and MDO3 have not been reported in any 
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nuclear processes, except for a very recent study, where MDO2 macrodomain was 
shown to be recruited to damaged DNA, when overexpressed from a plasmid (169). 
Altogether, very little is known about the functions of MDO1-3 and C6orf130. MDO1 
was initially detected in search for leukemia-relapse related proteins and was later 
reported to function in regulation of estrogen receptor alpha –mediated signalling (69, 
70, 111). One study indicated connection between disruption of MDO2 gene and onset 
of Kabuki’s syndrome (102). However, contradictory results were obtained in a later 
screen, in which similar gene disruption was detected in three healthy individuals (19). 
MDO3/GDAP2 was initially found in a screen for genes induced by ganglioside 
synthase expression in a mouse neuroblastoma cell line (98). It was shown to be 
expressed mainly in brain and testis, but the functions of MDO3 have not been studied 
(98). In this work I have shown that MDO1, MDO2 and MDO3 can potentially reside 
in the cytoplasm, and that they have distinct properties in NAD+ metabolite binding, 
which can to a certain extent be explained by differences in the substrate binding 
pocket (II). C6orf130 (Uniprot entry Q9Y530, (75)) was found very recently and was 
therefore not included in my study. 
1.6.2 Viral macrodomains 
In viruses macrodomains are found only in a small subset of positive-strand RNA 
viruses, namely coronaviruses, alphaviruses, rubella virus and HEV (42, 62). 
Macrodomains are found in non-structural proteins of these viruses and they reside 
inside multi-domain proteins surrounded by different domains depending on the virus. 
Several structures of viral macrodomains have been recently obtained (42, 106). Viral 
macrodomains share the conserved features of the ADPR binding pocket, including an 
aspartate residue (D10 in CHIKV) in close proximity to the adenine moiety of the 
ligand, flexible glycines (G30, G32 and G112 in CHIKV) in both sides of the 
phosphates of ADP, and an aromatic residue near the distal ribose (Y114 in CHIKV) 
(Fig. 6B) (42, 105). We have shown that viral macrodomains bind NAD+ metabolites 
including ADPR and have a modest enzymatic activity on ADPR1-P (I), (105). 
ADPR1-P hydrolysis activity has been shown to be dispensable for a coronavirus in 
cell culture (135). 
Recently two macrodomains, having no sequence similarity with the earlier 
recognized members of the family, were discovered (22, 76, 166). These domains 
from SARS-CoV are called SARS unique domain N and M (SUD-N and SUD-M) (for 
N-terminus and middle). These proteins were not recognized as macrodomains by 
computational searches, and they are totally devoid of conserved amino acids that 
form the ADPR binding pocket (166). Interestingly, these domains reside in the same 
protein with SARS-CoV X-domain, the more typical macrodomain in SARS-CoV. 
Although SUD macrodomains share no sequence similarity with X-domain or other 
known members of the macrodomain family, they have a similar fold consisting of a 
central twisted six-stranded ? sheet surrounded by alpha helices on both sides, and 
clearly classify as macrodomains (22, 166).  
Human macrohistone was detected as the closest homologue of SUD-N and 
SUD-M with the rmsd 2,5 Å and 2,8 Å when superimposed to SUD-N and SUD-M 
respectively (112/115 out of 184 of C? atoms) (166). SUD-N and SUD-M 
macrodomains do not bind ADPR; instead they have been shown to bind G-
15
quadruplexes and RNA (76, 166). Based on mutational analysis, binding of short RNA 
seems to  be  mediated  by  a  site  located  in  a  divergent  loop  between  -helix  2  and  -
sheet  3  in  SUD-M,  which  is  distinct  site  from  that  of  ADPR  binding  site  in  other  
macrodomains (166). The loop region corresponds to region between 1 and 3 in 
CHIKV macrodomain that is shown in figure 4.  
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Figure 6. Amino acids in macrodomain ligand binding pocket are highly conserved. 
(A)Multiple sequence alignment of macrodomain proteins from various origins was 
made with clustalW and modified with Jalview (182). Amino acids with over 60% 
conservation amongst aligned proteins are highlighted in colour. Amino acids around 
the ligand binding pocket, which are shown in (B) are indicated by triangles below the 
sequences. The sequence names for non-human proteins begin with the organism 
name and are followed by the database annotation for the protein; SARSnsP3 refers to 
the “X-domain” of SARS-CoV. (B) CHIKV macrodomain in complex with ADPR 
ligand is shown with hydrogen bonds are depicted in dotted lines. Amino acids that 
have been mutated in alphavirus macrodomains (as reported in II and (105)) are 
marked with asterisk. Corresponding residues in SARS coronavirus are numbered in 
red. Modified from ref. (105). 
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2 Aims of the study 
The aim of this study was to elucidate the functions of alphavirus nsP3 in alphavirus 
replication, especially in the context of virus–host interactions. The study was divided 
into two parts. The first part considers the properties of the nsP3 macrodomain, and 
the latter part concentrates on the functions of the hypervariable region in nsP3. The 
specific aims of the projects were: 
1. to characterize the biological properties of viral macrodomains  
2. to find out whether the properties of macrodomains are conserved and which 
(if any) host cell macrodomain has the same properties as viral macrodomains 
3. to characterize the functions of the proline motifs in nsP3 HVR in vitro and in 
vivo 
4. to clarify the role of nsP3 HVR in replication complex internalization  
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3 Materials and methods 
Materials and methods are explained in original publications as indicated in table 1 
and table 2. Additional methods that have been not used in publications are detailed 
below. All virus work has been conducted with viruses originating from strains SFV4 
and SINV Toto1101. 
 
Table 1. Materials used in this work. 
Materials Publication
Plasmids  
pHAT I, II 
pDEST14 I 
pEGFP-N1 II 
pcDNA4/TO II 
pmtYFP II 
pEBPP III 
pSFV4 (pSP6-SFV4) III 
pToto1101 III 
Antibodies  
anti-MDO1 II 
anti-nsP3 (rabbit) II, III 
anti-nsP3 (guinea pig) III 
anti-EGFP II 
anti-dsRNA (J2) III 
anti-Amphiphysin-1 (N19) III 
anti-Amphiphysin-2 (H100) III 
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Table 2. Research methods used in this work.
Method Publication
Protein assays  
Protein expression and purification I, II 
ADP-ribose binding assay I, II 
Appr-1´´pase activity assay I, II 
Poly(ADP-ribose) synthesis and binding assay I, II 
PARG activity assay II 
polyA binding assay II 
Protein structures  
Structure determination and modeling of SARS CoV macro I 
Structure prediction for MDO1 II 
Cell culture and cell manipulation  
Cell lines  II, III 
Cell culture methods II, III 
Transfections II, III 
Immunological methods  
Western blotting II, III 
Immunoprecipitation III 
Indirect immunofluorescence II, III 
DNA and RNA techniques  
Cloning and mutagenesis II, III 
Quantitative PCR III 
RNA production and virus stocks III, unpubl. 
Microscopy and data analysis  
Wide field microscopy II 
Confocal microscopy III 
Image processing (ImageJ) III 
Deconvolution (Autoquant) III 
Colocalization analysis (Imaris Bitplane) III 
3D whole cell modeling (Imaris Bitplane) III 
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Virus stocks and infectious center assay  
BHK (baby hamster kidney) cells were grown on 10-cm plates until nearly confluent. 
The cells were detached with trypsin and washed once with phosphate-buffered saline 
(PBS). 1 µg of in vitro transcribed viral genomic RNA was used to transfect cells from 
one plate (~107 cells) collected in 800 µl of PBS. Cells were electroporated with two 
consecutive pulses of 850 V and 25 µF in a Bio-Rad Gene Pulser apparatus in a 0.4 
cm cuvette. A 720 µl aliquot of the electroporation mixture was used to generate the 
primary virus stock. These cells were immediately diluted with 10 ml of complete 
BHK medium and seeded onto a 10-cm dish. The medium was harvested when 
cytopathic effect (CPE) appeared (at 24 h for the wild-type virus and 48 h or 72 h for 
mutant viruses). The remaining 10% of the electroporation mixture (corresponding to 
0.1 µg RNA) was used in an infectious center assay. Tenfold dilutions of the mixture 
were immediately prepared in minimal essential medium (MEM) containing 0.2% 
bovine serum albumin (BSA). The dilutions were seeded onto 6 well plates of 
confluent BHK cells. After two hours, the inoculum was replaced with nutrient 
agarose in complete BHK medium. After incubation at 37°C for 48 to 72 h, plaques 
were visualized by staining with neutral red. 
 
Virus growth curves  
Dishes were prepared as explained above for virus stocks and 200 l of growth 
medium was removed  at indicated time points and diluted 1:1 in Dulbecco’s essential 
medium + 0,2% BSA. 10 % glycerol was added and the samples were stored in -70 
°C. Duplicates of each sample were titrated using plaque assay as described earlier 
(82).  
 
Imaging of P13 and P13ZsG 
Human cervix epitheloid carcinoma (HeLa) cells or BSR-T7 cells (20) cells were 
transfected by using Exgen 500 (Fermentas), according to manufacturer’s instructions, 
with plasmids P13-pcDNA4/TO or P13ZsG-pTM1 (155). HeLa cells were fixed at 4 h 
post transfection and visualized by immunofluorescence imaging using rabbit α-nsP1 
(87) and guineapig α-nsP3 as described in (III). For live cell imaging, LysoTracker 
Red DND-99 (Molecular Probes) was added to transfected BSR-T7 cells at 16 h post 
transfection. BSR-T7 cells were imaged 15 min after LysoTracker addition by using 
the Olympus IX71 TILL microscope supplemented with a 37°C chamber and CO2. 
Images were taken with UPlanSApo 60x 1.20 numerical aperture water objective. 
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4 Results 
4.1 Characterization  of  the  properties  of  macrodomains  (I,  II 
and unpublished) 
4.1.1 Macrodomains in ADPR binding 
In order to study the structural basis for ligand binding by a viral macro domain, 
SARS-CoV macrodomain structure was obtained by X-ray crystallography in the 
presence and absence of ADPR. Analysis of the data revealed a globular monomer, 
with approximate dimensions of 40 Å x 40 Å x 35 Å, consisting of a central seven 
stranded β-sheet flanked by two α-helices on one face and three on the other face (Fig. 
1A & B in I). Crystals obtained in the presence of ADPR revealed an ADPR molecule 
in a slightly bent conformation, located at the same side of the central β-sheet as the C-
terminal α-helix and partly buried inside of a mainly hydrophobic cleft (Fig. 2A in I). 
The adenine moiety is bound through a hydrogen bond between D23 and the NH2 
group on the adenine ring. This aspartate residue is strictly conserved in 
macrodomains and seems to serve as a basis for specificity for adenine moiety, as 
confirmed by structures of different ADPR bound macrodomains (81, 88, 105). Also 
other amino acids interacting with ADPR belong to motifs that are evolutionarily well 
conserved (Fig. 5 in I). For comparison the structure of CHIKV ADPR binding site is 
shown in figure 6. ADPR binding of SARS-CoV was confirmed by isothermal 
titration calorimetry and a dissociation coefficient (KD) value of ~ 24 M was obtained 
(Fig. 2B in I). ADPR binding of other viral macrodomains was also tested. For HEV 
macrodomain a weaker binding (KD ~50 M) was observed (I), but for SFV 
macrodomain no ADPR binding was detected (II).  
I wanted to compare the functions of the viral macrodomains with the 
macrodomains from the host cell. I was especially interested in host macrodomains 
that might reside in the cytoplasm and thus interact or compete with viral 
macrodomains. Therefore, I decided to study MDO1, MDO2 and GDAP2 that were 
not strongly associated with any nuclear processes. Yeast macrodomain protein Poa1p 
(151) was used as a control. For Poa1p, an enzymatic activity in ADPR1-P hydrolysis 
has been detected (151), and as expected, Poa1p bound also the end product of the 
hydrolysis, ADPR (KD = 2,9 M) (Fig. 3a in II; Table 1 in II). Human macrodomains 
MDO1 and MDO2 are even more potent ADPR binders than any of the viral 
macrodomains or the yeast macrodomain Poa1p. MDO1 and MDO2 bound ADPR 
with a KD value of 0.9 and 0.15 M, respectively. In contrast, GDAP2 had no affinity 
to ADPR (Fig. 3a in II; Table 1 in II). ADPR binding of MDO1 depends on the 
conserved glycines in two sides of the binding pocket (G182; G270) (Fig. 4 in II). 
When these amino acids were mutated to glutamic acid, no binding was detected. 
Interestingly, in GDAP2 there are no glycines in these positions, but instead K-N-P 
residues correspond to glycines 180-182 in MDO1 and alanine replaces G 270 (Fig. 1a 
in II). 
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4.1.2 Macrodomains as ADPR1-P hydrolyzing enzymes 
All the three viral macrodomains (from HEV, SARS-CoV, SFV) performed ADPR1-P 
hydrolysis, but the enzymatic activity of SFV macrodomain was rather poor (Fig. 4B 
&  C  in  I; Fig. 2 in II). Human macrodomains from MDO1 and MDO2 were also 
potent hydrolysis enzymes, but GDAP2, which was incapable of ADPR binding, could 
not hydrolyze ADPR1-P. When mutations were introduced to the binding pocket of 
SARS-CoV macrodomain in the close vicinity of the distal ribose moiety of the bound 
ligand, hydrolysis of the phosphate was impaired. Several mutations (N38A, H46A 
and G47A/G48A) decreased the hydrolysis activity of the protein and two mutants 
(N41A and F133A) were totally inactive in hydrolysis (Fig. 5A and B in I). Some of 
these mutations probably affect ADPR binding, whereas some could have a direct role 
in the dissociation of the distal phosphate. For example mutating G47/G48 in SARS-
CoV macrodomain probably decreases the hydrolysis activity because of reduced 
substrate binding. These amino acids correspond to G182 and G183 in MDO1 that 
were shown to impair ADPR binding by MDO1. In another study we found that 
macrodomains from three alphaviruses, CHIKV, VEEV and EEEV also performed 
ADPR1-P hydrolysis, and that Y114A mutation in CHIKV (corresponding to F133A 
mutation in SARS-CoV) was detrimental to this activity (105). Based on those 
findings and work presented here, it seems likely that an aromatic amino acid in this 
position (Y114, Fig. 6) is needed for ADPR1-P hydrolysis. 
4.1.3 PAR binding by viral and human macrodomains 
Most of ADPR in eukaryotic cells is thought to exist in the form of PAR. 
Consequently, I decided to study whether some of the macrodomains studied (listed in 
Fig 1b in II) could also bind PAR. It turned out that viral macrodomains from SFV, 
HEV and SARS-CoV bound PAR by an interaction that could not be competed by 
mono-ADPR as  was  tested  for  SFV and HEV (I, II). Interactions between PAR and 
SARS-CoV macrodomain were modelled by constructing a di-ADPR-macrodomain 
combination in silico (Fig. 7 in I). From the obtained structure, it seems likely that 
macrodomain would bind to the end of PAR in a capping manner, so that last ADPR 
would sit inside of the ligand binding pocket, but amino acid residues outside of the 
pocket might also participate in the binding.  
Of the human macrodomains studied here, only MDO1 bound PAR very 
efficiently, whereas MDO2 and GDAP2 gave only a very weak signal from labelled 
PAR (Fig. 3b in II). For GDAP2 this could be anticipated, since it did have no affinity 
to monomeric ADPR. The differences between PAR binding by MDO1 and MDO2 
are rather intriguing, since they share an almost identical ligand binding pocket, but 
have very different affinities towards PAR. This indicates that there are other factors, 
in addition to ligand binding pocket, that contribute to the binding of PAR. 
4.1.4 Some macrodomains are poly(A) binding modules 
I  wanted  to  test  whether  polymer  binding  by  macrodomains  was  specific  to  PAR,  or  
whether other charged molecules could also be bound. It turned out that some of the 
macrodomains were able to bind also poly(A), but surprisingly the poly(A) binding 
did not correlate with the PAR binding ability of the proteins. SFV macrodomain and 
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HEV macrodomain were potent PAR binders and bound also poly(A) with good 
affinity (II). MDO1 bound PAR efficiently, and was also able to bind poly(A), 
although not as efficiently as viral macrodomains from SFV, HEV and SARS-CoV . 
MDO2 was not efficient in PAR binding and had no affinity to poly(A). Interestingly 
GDAP2, which was found inactive in all ADPR-related assays, including the binding 
of PAR, was found to be a potent poly(A) binder (Fig. 3c in II).  
4.1.5 Mutations in nsP3 macrodomain cause defects in SFV reproduction 
(unpublished) 
SFV macrodomain mutant viruses had been produced in our laboratory before the 
structure of macrodomain was known. Mutations were designed based on the sequence 
conservation in the macrodomains, and five of the most highly conserved amino acids 
were selected for mutation. Four different mutants were produced: a double mutation 
of N21A and N24A (N21+24A), H67A, P107G and G112S. Based on the comparison 
with structures of SARS-CoV macrodomain (Fig. 4a in I; 5a in I) and CHIKV 
macrodomain (105), these mutations map into the ligand binding pocket. N24 and 
G112 in CHIKV macrodomain form hydrogen bonds with ADPR. N21, H67 and P107 
reside in the close vicinity of the ligand bind pocket, but seem not to interact directly 
with ADPR.  
Both mutations (N21+24A, G112S) changing the amino acids participating in 
the hydrogen bonding of ADPR caused a delay in virus production in BHK cells. 
P107G mutant virus had only a slight replication delay, whereas H67A mutant was 
most severely affected (Fig. 7). In an infectious center assay, the infectivity of the 
corresponding RNAs was assessed in a single round experiment (see materials and 
methods). Almost no plaque forming viruses were detected for H67A (~12 plaque 
forming units (pfu)/g RNA). Thus this mutation must be quite destructive for SFV, 
and the growth of the virus probably arises from compensatory mutations. Other 
mutants had also reduced infectivity, resulting in two to three logs lower pfu 
production (Table 3). 
Based on the structure comparison with CHIKV macrodomain, these mutations 
reside in a close vicinity of the ADPR binding pocket, and two of them affect amino 
acids that have been indicated in the direct binding of ADPR (N24 and G112). 
Consequently, this data indicates that ligand binding through macrodomain is 
important for virus multiplication in vivo.  
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Table 3. Infectivity of SFV macrodomain 
mutant viruses as measured by 
infectious center assay. 
 
Figure 7. Growth curves of the SFV macrodomain mutants. Growth curves were 
obtained from a single round experiment after RNA transfection. 1 μg of infectious 
RNA was electroporated into BHK cells and aliquots of growth media were collected 
at the indicated time points. Titres of the released viruses were measured by plaque 
assay. 
 
4.1.6 Subcellular localization of macrodomain proteins 
The subcellular localization of human macrodomain proteins was studied in HeLa 
cells by using either C-terminally EGFP-tagged (enhanced green fluorescent protein 
tagged) proteins or detection by specific antibodies. Proteins expressed from a plasmid 
were analysed by Western blot to check that full length proteins were expressed (Fig. 
5a in II). Expression of MDO1 resulted in two products, the larger of which 
corresponds to full length protein (62 kDa), and shorter product corresponding to ~56 
kDa protein. The shorter protein could be either translation product from the second 
in-frame methionine (M83) or could be a cleavage product produced from the full 
length protein in vivo. Translation of the shorter protein would give a 243 aa long 
product, whereas cleavage of a putative mitochondrial localization signal (P = 0.998, 
Mitoprot (24)) would yield 248 aa product, and thus neither of these possibilities can 
be ruled out based on the Western blot results (II). 
The full length MDO1 (325 aa) was found exclusively localized into 
mitochondria. When a shorter form (243aa), corresponding the translation from second 
in-frame methionine, was expressed, a diffuse nuclear-cytoplasmic localization was 
detected. C-terminally tagged EGFP-MDO2 and EGFP-GDAP2 were also found 
diffused throughout the whole cell. This indicates that all of these proteins are 
potentially cytoplasmic residents (II).  
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4.2 Virus-host interactions mediated through nsP3 C-terminus 
(III and unpublished) 
4.2.1 The HVR of nsP3 functions in SFV replication complex internalization 
(unpublished) 
It has been shown that SFV replication complexes first form on plasma membrane, 
from where they are internalized in a mechanism dependent on phosphoinositide 3-
kinase (PI3K), actin cytoskeleton and microtubules, into virus induced endo-lysosomal 
organelles (157). Recently, it was found that the internalization of replication 
complexes can be blocked by P13K inhibitors or by deletion of 50 amino acids in the 
phosphorylation region of nsP3 HVR (aa 319-368) (10, 157). To examine more 
closely the effect of phosphorylation on the transport of replication complex into 
CPVs, three different deletion mutants were studied (Fig. 8A). The original 50 amino 
acid deletion was divided in two halves, 24 and 26, to dissect the role of different 
phosphorylation determinants in internalization. Vihinen and co-workers (180) 
reported that when nsP3 26 4S-4A mutant was studied, no phosphorylation was 
detected. Consequently, this mutant was also included in these studies to see whether 
it could retain the replication complexes on the plasma membrane similar to 50 
mutant.  
In cells infected with alphaviruses, double stranded RNA (dsRNA) is only 
detected in the viral replication complexes, where it occurs as a replicative 
intermediate in RNA replication. The localization of replication complexes was 
studied by dsRNA staining of BHK cells infected with wt or mutant SFV (Fig. 8 B-F). 
Replication complexes of 50 virus were detected at the plasma membrane at 8 h p.i., 
whereas wt replication complexes localized in CPVs. Neither 24 nor 26 mutant 
viruses affected the localization of replication complexes and the CPVs formed similar 
to wt. Interestingly, a phosphorylation deficient mutant 26 4S-4A also formed CPVs 
at 8 h p.i. However, the transport of the replication complexes of 26 4S-4A virus was 
delayed compared to wt (Fig. 9).  
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Figure 8. Effects of nsP3 phosphorylation on SFV replication complex intracellular 
localization. (A) Design of nsP3 mutants with deletions in phosphorylation region. 
Nomenclature of the mutants and corresponding mutations are indicated in the left. 
Point mutations are presented with red lines, highlighted with asterisks. (B-F) BHK 
cells were infected with SFV wt or mutant viruses with 50 plaque forming units (pfu) 
per cell. Cells were fixed at 8 h post infection (p.i.) and stained with anti-nsP3 and 
anti-double stranded RNA (dsRNA) antibodies. Wt replication complexes stained with 
dsRNA and nsP3 antibodies were detected in the CPVs (B), but 50 replication 
complexes remained at the plasma membrane, (C) whereas shorter deletions (24, 
26) or a combination of deletion and point mutations (26 4S-4A) did not affect the 
localization of the CPVs, and the localization was similar to wt (D-F). 
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Figure 9. Severe reduction in SFV nsP3 phosphorylation causes delay in CPV 
formation. BHK cells were infected with 50 pfu of SFV wt and 26 4S-4A and fixed at 
4 h p.i. and stained with anti-nsP3 and anti-dsRNA antibodies. Wt replication 
complexes were detected in CPVs already at 4 h p.i. (A), whereas 26 4S-4A remained 
in small endocytic vesicles and on the plasma membrane (B). 
 
It is known that nsP1 is the membrane anchor of the replication complex (125, 
146). NsP1 seems to be responsible for directing replication complexes first to plasma 
membrane, since nsP1 (and P12) localize to plasma membrane when expressed alone 
(146). Polyprotein P123 is transported to an intracellular vesicular compartment (146) 
(Fig. 10 A-C). We wanted confirm that nsP3 alone is sufficient to induce the transport 
to vesicular compartment, and nsP2 is not needed for this purpose. In this study, an 
artificial protein P13 was constructed and fluorescent reporter ZsGreen (ZsG) was 
inserted inside of nsP3 in a position that has been shown not to interfere with the 
formation of replication complex and virus infection, and thus should not affect the 
folding nsP3(157). Western blot with nsP3 confirmed an expression of protein of 
correct size producing no degradation products that would be recognised by nsP3 
antibody (Fig. 10 D). When expressed in HeLa cells, nsP1 and nsP3 staining 
colocalized well in immunofluorescence and colocalization was detected in vesicle-
like structures (Fig. 10 E). However, over-expression of the construct seemed to lead 
to aggregation (not shown). When observed in BSR-T7 cells P13ZsG colocalized with 
acidic vesicles stained with lysotracker, indicating that nsP3 can drive the 
relocalization of nsP1 from plasma membrane to lysosomes (Fig. 10 F). Together 
these data indicate that nsP3 is sufficient and necessary for transport of replication 
complex to the vesicular compartment, and that the transport is dependent on 
determinants in nsP3 HVR. However, nsP1 is also needed for this process, at least as a 
membrane anchor of the polyprotein. 
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Figure 10. SFV P13 localizes to endosomes similar to P123 polyprotein. 
Localizations of nsP1 and nsP2 (cleaved from P12), P12CA (uncleavable) and 
P12CA3 (uncleavable) are shown as detected by Salonen et al. (A-C). Reproduced 
with permission from ref. (146). HeLa and BSR-T7 cells were transfected with P13 
and P13ZsG expression plasmids. Expression of P13 and P13ZsG was detected from 
transfected BSR-T7 cells by Western blot analysis with anti-nsP3 antibody (D). HeLa 
cells transfected with P13 were fixed at 24 h p.i. and stained with anti-nsP1 and anti-
nsP3 antibodies and analyzed by immunofluorescence microscopy (E). BSR-T7 cells 
transfected with P13ZsG were analyzed by live cell imaging after an addition of 
lysotracker for staining the acidic endosomal compartment (F).  
 
4.2.2 Alphavirus nsP3 binds SH3 domain proteins through a proline rich 
region in HVR 
All alphaviruses harbour in the C-terminus of nsP3 one or more proline rich regions of 
about 6-12 amino acids in length (Fig. 1a in III and  Fig.  3).  In  SFV  these  regions  
reside 40 amino acids downstream of the phosphorylation area in HVR. Sequences of 
the proline rich stretches closely resemble an Sh3BM consisting of conserved prolines 
and arginines. Consequently, we decided to assess whether alphavirus nsP3 could 
function in SH3 domain binding. For this purpose nsP3 proteins from SFV, SINV and 
CHIKV were used to screen a phage library containing the SH3 domains from 
virtually all the human SH3 domain proteins. NsP3 proteins turned out to be excellent 
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SH3 domain binders, giving over 1000-times enrichment of phages compared to the 
mock protein used as a control. The SH3 domains fished out by these proteins 
consisted almost purely of amphiphysin-1 and amphiphysin-2 (Table 4). 
 
Table 4. The identities of individual SH3 domain clones obtained after a single round 
of panning with SFV, SINV and CHKV nsP3. 
Full SH3 screen  SH3 screen w/o Amph2 
SFV nsP3:  SFV nsP3:
AMPH2  10/16 AMPH1 12/16 
AMPH1  4/16  CMS 1/3  3/16
CMS 1/3  1/16  CIN85 1/3  1/16 
CIN85 1/3   1/16    
SINV nsP3:   SINV nsP3: 
AMPH2  13/16  AMPH1    7/8 
AMPH1  3/16  SASH1 1/1     1/8 
CHIKV nsP3:  CHIKV nsP3:
AMPH2  13/16  AMPH1    8/8 
AMPH1   3/16     
 
The relevance of the detected SH3 domain binding was tested by studying full 
length amphiphysins. Both amphiphysin-1 and amphiphysin-2 bound to alphavirus 
nsP3 proteins from SFV, CHIKV and SINV (Fig. 2 in III). When the proline rich area 
was removed, no binding of amphiphysins was detected (Fig. 1B in III; 2 in III). 
SINV and CHIKV both contain only one proline cluster in their nsP3, whereas SFV 
contains two separate proline rich regions (Fig. 1A in III). When only the latter region 
in SFV nsP3 was removed, binding of amphiphysin did not decrease, leading to a 
conclusion that the first region alone is sufficient for efficient amphiphysin binding. 
However, the latter region alone can also bind amphiphysin, but the affinity is reduced 
compared to wt, especially in the case of amphiphysin-2. Thus simultaneous removal 
of both the region was needed for us to be able to study a mutant with no affinity to 
amphiphysin (Fig. 1B in III). 
We wanted to characterize in detail the Sh3BM of alphaviruses and for this 
purpose we decided to use SINV nsP3, which only contains one proline cluster. We 
mutated separately each amino acid in SINV proline motif: P-I-P-P-P-R-K-K. 
Mutations on the first proline (P421A) and in the arginine (R426E) totally abolished 
amphiphysin-1 and amphiphysin-2 binding, whereas P423A and P425A mutations 
seemed to reduce the binding slightly (Fig. 3 in III). These results confirm that the 
motif recognized by both amphiphysins represents an Sh3BM of the type PxPPxR. We 
didn’t examine the determinants in SFV proline clusters, but the PxPPxR motif is only 
found in the first of the two clusters, and it is possible that the second motif is specific 
for recognition of an SH3 domain from another protein, although it also binds 
amphiphysin in vitro. 
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4.2.3 SH3 domain binding by alphavirus nsP3 is important for virus 
replication in cell culture 
Amphiphysin-1 and amphiphysin-2 colocalize with SFV and SINV replication 
complexes in vivo (Fig. 4-6 in III). This binding is mediated by Sh3BM in nsP3 (Fig. 
2 in III), and the colocalization of nsP3 containing aggregates is lost when the motif is 
disrupted (Fig. 7 in III). However, some amphiphysin is still detected in association 
with the replication complexes (Fig. 6 in III; 7 in III). Even though amphiphysin-2 
colocalizes faintly with mutant replication complexes, it is not co-immunoprecipitated 
by nsP3 from these cells, indicating that amphiphysin is not bound to replication 
complex components of mutant virus (Fig. 2c in III and 7 in III).  
SINV mutant virus with disrupted Sh3BM replicated very poorly in HeLa cells 
compared to wt (Fig. 11). Replication of SFV P mutant was not as severely impaired, 
but the mutant virus formed CPVs more slowly than the wt virus, and the recruitment 
of amphiphysin to SFV P replication complexes was rather poor (Fig. 7A, B in III). 
Data analysis confirmed that there is a strong and significant colocalization between 
amphiphysin-2 and nsP3/dsRNA at 10 h p.i. in the case of wt SFV (Pearson’s 
correlation coefficient (r) = 0,67/0,75 (for nsP3/dsRNA respectively).  Instead, only a 
weak colocalization was detected (r = 0,48/0,52) in the case of SFV P (Fig. 7C in 
III). Consequently, the colocalization analysis supports the idea that amphiphysin is 
directly bound to replication complexes in wt infected cells, whereas in the cells 
infected with binding deficient mutant interaction between amphiphysin and 
replication complexes is more indirect, leading to less significant colocalization. 
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Figure 11. Mutation in SINV proline region site severely reduces virus replication. 
HeLa cells were infected with SIN wt (A) or R426E (B) at m.o.i. 50, fixed at 6 h p.i. 
and stained with antibodies against amphiphysin-2 and dsRNA. SIN nsP3 was detected 
from the fluorescent signal of conjugated cherry (pseudocolored in magenta, Ai and 
Bi) The overlay of dsRNA (viral replication complexes) and amphiphysin-2 staining is 
shown in the right (Aii and Bii). Colocalization of viral replication complexes (dsRNA 
staining) and amphiphysin-2 is seen in yellow. 
 
Since the immunofluorescence data indicated that SH3 domain binding is 
important for virus replication, we decided to assess the significance of proline rich 
motif for viral RNA replication. For this purpose total RNA from SINV and SFV 
infected cells was collected and the virus replication was assessed by using reverse 
transcription quantitative PCR (RT qPCR). As expected, the RNA replication by 
proline motif mutants was clearly delayed compared to wt virus. SFV mutant 
displayed a delay both in HeLa and BHK cells, whereas SINV mutant had a very 
severe delay in HeLa cells, but replicated close to wt levels in more permissive BHK 
cells (Fig. 8 in III). Consequently we can conclude that amphiphysin binding mediated 
by alphavirus nsP3 is important for RNA replication.  
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5 Discussion 
For years alphavirus nsP3 has been the mysterious replication protein, necessary for 
virus reproduction, but with no obvious clearly defined function in virus replication 
(78). Based on current evidence, nsP3 is needed for replication as a building block of 
the replication complex and together with nsP2 it seems to function in regulation of 
template specificity of the replication machinery (78, 160). However, one can ask 
whether it would be enough for evolutionary conservation of such a large entity as 
nsP3 to be just a structural building block.  
In the early years, mutational analysis was conducted leading to large amount of 
information on different complementation groups, temperature sensitive mutants and 
essential amino acids in all the nsPs including nsP3 ((68) and references therein). 
When the experimental data was combined with computer aided searches for protein 
domains, the enzymatic activities of nsP1, nsP2 and nsP4 were uncovered (62, 78). 
During the early 1990s it was revealed, how alphaviruses were able to achieve the 
whole replication cycle in cytoplasm, seemingly without the help of host proteins, with 
as little as four replication proteins on their own (51, 93, 150, 161). Curiously, no 
specific function for nsP3 was detected. There was not a single recognized domain in 
nsP3, which made its function difficult to address. Thus nsP3 remained somewhat a 
puzzle (reviewed in (78)). 
Interestingly, some of the nsPs turned out to have other functions not related to 
RNA replication. Most importantly, nsP2 was shown to shut down the host cell 
transcription and suppress host immune system (45, 48, 126). However, for nsP3 no 
function was proposed when cleaved from the replication complex. Rather, its 
importance remained questionable, since large parts of nsP3 could be removed without 
compromising the virus replication in cell culture (90). However, nsP3 was revealed as 
a phospho-protein (96, 127), and when phosphorylation-incapable viruses were 
introduced into mice, they were apathogenic (178). In fact, there are many other 
mutations mapping to nsP3 that also turn the virus apathogenic in mice (53, 163, 172). 
It seems that many pathogenicity factors reside inside nsP3 (172, 178), but since the 
old studies were mainly done in cell culture, many of these functions could not be 
revealed, since the host immune system probably plays an important role in these 
interactions.  
In recent years, virus-host interaction has gained growing amount of interest (8, 
58, 116). It is becoming evident that the original hypothesis of the host cell 
independent replication of positive strand RNA viruses is not accurate as such. 
Although the essential functions of RNA duplication are achieved by the viral 
machinery, it seems that many host proteins are recruited to viral replication 
complexes and are needed for efficient virus replication (11, 12, 39). Dissecting the 
virus-host interactions that determine the virulence and pathogenicity of a certain virus 
might provide a key for successful antiviral therapy, and analysis of alphavirus nsP3 
interactome may be a valuable tool to achieve this goal. 
In 1992, an atypical histone variant was found, consisting of a traditional histone 
core similar to histone 2A and another additional domain, and the new histone was 
named “macrohistone” for its large size (123). In 1998, it was recognized that the “X-
domain” of alphavirus nsP3 belongs to the same evolutionarily conserved protein 
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family as the non-histone domain of macrohistones (124), and in 2003 the structure of 
macrodomain was finally revealed (6). However, even though several macrodomain 
structures have now been solved, the functions of this domain remain somewhat 
unclear, and we are only getting first insight into the functions of macrodomain. This 
underlines the fact that information on protein structure does not necessarily reveal the 
protein function. 
In this work I have dissected the functions of different domains of nsP3, thus 
trying to shed some light into the functions of this protein. During this work it has 
turned out that the macrodomains might be more diverse group than originally 
thought. In addition, conserved Sh3BMs were found in the “non-conserved” C-
terminus of nsP3 and were shown to be important for virus replication. In the chapters 
below the macrodomain and the determinants inside nsP3 HVR will be discussed in 
the context of how they might benefit virus replication, and the functions eukaryotic 
macrodomains will be also considered. 
5.1 Human and viral macrodomain proteins 
Recent studies have shown that human macrodomain proteins participate in 
transcriptional regulation in a PARylation dependent manner, and it has been 
postulated that PARylation is an epigenetic flag that regulates gene expression in a 
similar manner compared to methylation or acylation (2, 64, 144, 169). PAR induced 
chromatin remodelling functions have been confirmed for macrohistone mH2A1, and 
DNA helicase Alc1 (2, 64, 169). Also MDO1 has been shown to be recruited by 
chromatin PARylation and indicated in the transcriptional regulation of estrogen 
receptor (70, 169). Nevertheless, the cellular functions of many macrodomain proteins 
remain unknown, although most of them bind PAR in vitro (II), (1, 81, 88, 169).  
It will be interesting to see whether some human macrodomains have other 
functions than regulation of nuclear chromatin. One interesting case is MDO1, which 
contains a mitochondrial targeting sequence in its N-terminus (II). As shown in this 
work, MDO1 is targeted to mitochondria when translated as a full length protein. This 
would indicate a mitochondrial function for MDO1 (II). Recent evidence suggests that 
a fraction of PARP-1 is localized to mitochondria and participates in the maintenance 
of mitochondrial DNA (141). In addition, PAR degrading enzymes have been shown 
to function in mitochondria, indicating mitochondrial PAR metabolism independent of 
nuclear PARylation (113, 119, 184). Thus it could be speculated that MDO1 would be 
recruited to mitochondria upon mitochondrial stress, in a similar way compared to 
recruitment of macrodomain proteins by PARylated nuclear chromatin.  
PARP-1 is the main enzyme producing PAR in mammalian cells (154). For a 
long time it was thought to be the only enzyme responsible for PARylation in 
eukaryotic cells (154). Later, altogether 17 PARPs have been recognized in different 
compartments of the cell (73, 120). These PARylating proteins have been detected in 
telomere maintenance and in cytoplasmic vault structures as well as in mitochondria 
(7, 141). Thus it seems likely that many undiscovered functions exist for macrodomain 
proteins in connection with different PARPs. It should also be noted that despite the 
current nomenclature, some PARPs like PARP-10 and PARP-14 catalyze mono-ADP-
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ribosylation rather than PARylation (84). In addition, several mono-ADPR-
transferases exist in eukaryotes, and there is growing evidence for the physiological 
importance of mono-ADP-ribosylation of eukaryotic proteins (14, 31, 38, 73). This 
poses a question whether human macrodomains would function also in mono-ADPR 
binding. Many macrodomains, including proteins from human origin, have been 
shown to bind mono-ADPR in vitro (I, II), (88, 105, 121). Bacteria contain also 
macrodomains, and bacterial proteins are known to be modified by mono-ADP-
ribosylation, but not by PARylation (27, 43). This is a strong indication that in 
addition to PAR, monomeric ADPR is a binding partner for some macrodomain 
proteins. Furthermore, when an archeal macrodomain was artificially expressed in 
mammalian cells, it was able to pull down mono-ADP-ribosylated proteins (32). 
Although currently there is no knowledge of the function of eukaryotic macrodomains 
in binding of mono-ADP-ribosylated proteins, macrodomain interactions with mono-
ADP-ribosylated proteins is a promising direction for future research. 
Based on the current model, as evidenced by the SARS-CoV macrodomain 
structure analysed in this work, macrodomains bind PAR in a capping manner, and 
can only interact with the last ADPR unit in the chain (I), (169). Since both ADPR and 
PAR seem to be bound to macrodomains in a similar manner mediated by the 
conserved amino acids in the ligand binding pocket, it will be interesting to see how 
the binding specifity towards PAR or ADPR is regulated in macrodomains. In vitro 
both ADPR and PAR are bound by the same macrodomain proteins, but it is not 
known whether this happens also in vivo (I, II). It is possible that some amino acids in 
macrodomain surface participate in the binding of PAR chain and thus could 
differentiate the PAR binding macrodomains from ADPR binding macrodomains. The 
binding partners of macrodomain proteins may also be regulated by multi-protein 
interactions in macrodomain containing complex, and recognition sites in the 
PARylated protein might be involved in the interaction. Altogether, more data is 
needed for the determination of the binding specificities of macrodomains. 
In this work I have shown that some macrodomains can bind also poly(A) (II). 
This finding was confirmed by our collaborators in another study, where CHIKV 
macrodomain-triadenine complexes were examined by X-ray crystallography (105). It 
was shown that adenine rich RNA binds to the same site as the adenine moiety of 
ADPR, but also interacts with residues outside of the pocket (105). As indicated by the 
results of my work, different determinants seem to be needed for poly(A) and ADPR 
binding, evidenced by proteins such as GDAP2 that bind poly(A) but not ADPR (II). 
This implies that poly(A) binding is a specific feature of certain macrodomains. 
Interestingly, two new macrodomains with no sequence similarity with “traditional” 
macrodomains were recently discovered in SARS-CoV (22, 166). These 
macrodomains do not have a conserved ligand binding pocket, but they bind RNA 
through a loop structure in a distinct site (166). These findings indicate that the 
macrodomain family might be more diversified than thought before, and different 
lineages might be found sharing a similar fold but different substrate binding 
determinants. 
Macrodomain function is important but not obligatory for alphavirus replication 
(Fig 7, Table 3), (122). Although none of the tested mutations conferred total lethality, 
macrodomain function seems to be beneficial for virus replication, since single point 
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mutations in the binding pocket restrained viral replication (this work; 4.1.5). It is 
interesting to speculate whether the functions of viral macrodomains are related to 
PAR/ADPR binding, poly(A) binding or whether they both could be relevant 
substrates. It could be hypothesized that poly(A) binding would have a function in 
viral RNA replication, since the viral RNA from alphaviruses, coronaviruses and HEV 
is polyadenylated. PAR binding mediated by viral macrodomains could be related to 
recruiting of PARylated host proteins for replication purposes, or it could aim to 
sequester PARylated proteins in a similar way that will be discussed for amphiphysin 
below. Various host proteins have been shown to bind to nsP3 containing protein 
complexes and some of these proteins, such as vimentin and 14-3-3 are known to be 
ADP-ribosylated (25, 32, 148). Whether macrodomain plays a role in binding of these 
host proteins will be a topic for a further study. 
Based on the differences between macrodomains studied in this work, it seems 
that in contrast to our initial hypothesis, viral macrodomains do not have the same 
properties as a certain host cell macrodomain. None of the eukaryotic macrodomains 
analysed in this work has the same functional characteristics as the viral 
macrodomains; high affinity towards PAR and poly(A), and low affinity for ADPR 
(II), and others have functions associated with nuclear chromatin (2, 64, 169). 
Furthermore, from a structural point of view, viral macrodomains are not related to 
each other, and have been most likely acquired by different virus groups 
independently during their evolution (22, 32, 105). Since viral macrodomain functions 
have been obtained independent of each other, they might originate from different 
eukaryotic proteins and are likely to have diverse binding partners. Macrodomains 
with a conserved binding pocket may bind to different ADP-ribosylated target proteins 
and the non-conserved macrodomain proteins SUD-M and SUD-N from SARS 
coronavirus are very likely to have a different substrate.  
5.2 Multifunctional nsP3 HVR 
Earlier, it was thought that natively disordered protein stretches would act mainly as 
domain linkers, without any function of their own (41). In this context, it would be 
difficult to understand, why such a large unstructured sequence as alphavirus nsP3 
HVR would be conserved throughout virus generations. However, quite recently 
people have started to realize that these disordered regions often carry important 
signalling and interaction motifs. Various cellular proteins recognize their interaction 
partners based on short linear motifs of 4-8 amino acids in length that are present in 
unstructured regions (52). Many eukaryotic networking proteins, which interact with 
multiple proteins, have long segments of intrinsic disorder, and this probably allows 
them to interact more flexibly with various partners (71). Through these proteins 
having regulatory short motifs many important cellular functions involving actin 
dynamics, endocytosis and exocytosis are regulated. Examples of proteins binding to 
their short linear motifs include Src kinases, amphiphysins, endosomal sorting 
complex required for transport (ESCRT) components and many others (40).  
Large natively disordered protein segments are a typical for many viral proteins. 
One example is human immune deficiency virus (HIV) Gag protein that has been 
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shown to possess functional short linear motifs including “the late domains” for 
ESCRT binding (54, 131). Other viruses have been shown to contain short motifs for 
binding host proteins such as clathrin, dynein, cyclins and caspases (16, 74, 101, 165). 
Most likely, the currently recognized linear motifs in viral proteins are just the tip of 
an iceberg, and many more are to be found now that tools for linear motif search are 
available (33, 134). Hijacking host pathways through short linear motifs may be a very 
prominent tool for viruses, since usually only one or two mutations would be 
necessary for the formation of a novel motif. The mutation frequency of RNA viruses 
is 10–6–10–4 mutations per position per generation, and thus the appearance of a new 
motif can be a very rapid process (147). However, although in some cases a short 
linear motif alone is enough for functional protein-protein interaction, it should be 
kept in mind that often intrinsically disordered proteins do obtain a secondary structure 
upon ligand binding and regions other than the short linear motif are needed for 
folding and tight binding (41).  
Alphavirus HVR is an unstructured protein region that tolerates large deletions 
(15, 53, 90). However, even though the mutants with deletions in HVR replicate in cell 
culture, they often show reduced pathogenicity in animals (53, 178). Consequently, it 
seems likely that host-interaction factors are located in alphavirus HVR. Based on 
sequence data, there are short motifs in HVR that are conserved in all the alphaviruses, 
although there is some variation in the localization and number of certain motifs. In 
this thesis one of the motifs in HVR, namely the Sh3BM, has been characterized, and 
we have shown that phosphorylation region in nsP3 HVR is responsible for endosomal 
localization of the replication complex.   
5.2.1 Replication complex internalization mediated by nsP3 HVR 
The work presented in this thesis confirms that nsP3 alone without accompanying 
nsP2 is sufficient to direct the membrane bound polyprotein to endosomal 
compartment, and that a region inside HVR is responsible for the targeting. I have 
shown that the there is not a unique phosphorylation site in nsP3 that would drive the 
internalization of replication complexes, but rather phosphorylation of nsP3 in general 
is needed. Interestingly, SFV mutant (26 4S-4A) that has earlier been shown to lack 
any recognizable phosphorylation (180) was not able to stop internalization, in 
contrast to unphosphorylated SFV 50. However, the internalization of 26 4S-4A 
replication complexes was delayed compared to the wt. This could be explained by the 
hypothesis, supported by unpublished data from our group, that in this mutant virus a 
low level of phosphorylation is remaining, but it falls below the sensitivity of the 
labelling assay used in the early phosphorylation study (179, 180). This remaining 
phosphorylation could serve as a basis for internalization although with lower 
efficiency than the more prominent phosphorylation in wt virus. 
It is not known, which cellular kinase is responsible for phosphorylation of 
HVR, but in silico searches for kinase binding motifs might provide a hint for host 
proteins associated with this process. Practically all alphaviruses contain an FxxF 
motif, in one or two repeats, close to the nsP3 C-terminus. In VEEV, a 10 amino acid 
region “VITREEFEAF” that contains the FxxF motif, has been shown to be the only 
region (other than the 3/4 cleavage site) in HVR intolerant to amino acid insertions 
(15). This is a strong indication for functional motif at this location. Interestingly, a 30 
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aa C-terminal deletion in SFV nsP3, that removed the FxxF motifs, was shown to 
disrupt the endosomal localization of an uncleavable polyprotein P12CA3 (174). Thus 
it could be hypothesized that the FxxF motif is needed for the endosomal targeting of 
alphavirus replication complexes. 
In eukaryotic cells a C-terminal hydrophobic FxxF motif is found exclusively in 
the targets of 3-phosphoinositide-dependent protein kinase-1 (PDK-1) (18). PDK-1 is 
a serine/threonine kinase responsible for phosphorylation of several downstream 
kinases of phosphoinositide 3-kinase (P13K) signalling pathway, most notably the 
central effector Akt, and the efficiency of phosphorylation often depend on the FxxF 
sequence present in the substrate (17). PDK-1 binds through its pleckstrin homology 
domain to phosphatidylinositol 4,5-bisphosphate (PIP2) and phosphatidylinositol 
3,4,5-triphosphate (PIP3), created by PI3K. The activity of PDK-1 is strictly regulated 
by PI3K that is needed for creating critical threshold of PIP2 / PIP3 (26). Interestingly, 
PI3K has been recently shown to be crucial for SFV replication complex 
internalization, and there are strong indications that the internalization is caveolin 
dependent (10, 157). Furthermore, PI3K and PDK-1 have been shown to associate 
with caveolae in several cell lines including fibroblasts, the primary target cells of 
alphavirus infection (ref. (153) and references therein). Consequently as a 
serine/threonine kinase that is intimately linked to PI3K pathway, PDK-1 is a 
promising candidate for a kinase participating in nsP3 phosphorylation.  
An interesting exception in the endosomal localization of alphavirus replication 
complexes was found in this work and by others (III), (49). The replication complexes 
of SINV are detected predominantly at the plasma membrane throughout infection in 
mammalian cell culture (HeLa, Neuro2A, BHK and 3T3 cells) even though SINV is 
phosphorylated in nsP3 and contains intact FxxF motif (III), (49). However, SINV 
replication complexes localize to CPVs in C710 insect cells (49), which shows that the 
basic determinants needed for replication complex internalization are intact, but only 
some factor needed in mammalian cells is missing. Currently, this is the only case 
indicating that alphaviruses could maintain their whole replication cycle on the plasma 
membrane, and more studies are needed in order to determine whether some 
alphaviruses do not form CPVs in their natural mammalian hosts, or whether this is a 
feature seen only with a specific virus strain or cell lines. 
5.2.2 Functions of amphiphysin in alphavirus replication 
In this work I have shown that amphiphysin-1 and amphiphysin-2 colocalize with the 
forming replication complexes early in infection and that association between 
amphiphysin-2 and replication complexes is maintained throughout the infection. 
Furthermore, it was proven that amphiphysins are bound to viral replication complexes 
through direct interaction with a specific motif in nsP3 HVR (III). 
Amphiphysins are membrane binding proteins that contain a banana shaped 
membrane bending BAR (Bin/Amphiphysin/Rvsp) domain. There are two 
amphiphysin genes in the human genome: Amphiphysin-1 and Bin1/Amphiphysin-2 
(133). Amphiphysin-1 is expressed almost solely in neurons, whereas amphiphysin-2 
is ubiquitously expressed and spliced into more than 10 isoforms (133). All 
amphiphysins have an N-terminal N-BAR domain and a C-terminal SH3 domain. The 
N-BAR domain contains in addition to BAR an N-terminal amphipathic helix that 
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binds lipid membranes and is thought to make N-BAR capable of inducing membrane 
curvature (34). Amphiphysin-1 has also a clathrin binding domain that is needed for 
binding of clathrin containing vesicle budds at the plasma membrane, and its functions 
are thought to be related with neuronal endocytosis (186). Amphiphysins bind through 
their SH3 domains proteins such as c-myc and dynamin, and SH3 domain mediated 
interactions are required for regulation of amphiphysin functions (44, 130, 133, 143, 
185).  
SH3 domain mediated interactions have been detected for few other viral 
proteins, including HIV Nef and Kaposi's sarcoma-associated herpesvirus’ K15, which 
bind Src-family kinases (92, 129, 171). Amphiphysin-2 binding has been shown for 
HCV non-structural protein 5A (117, 187). Many viruses are known to modulate host 
cell signalling pathways through binding host regulatory proteins in order to create a 
more beneficial environment for viral replication (79).  Interestingly, positive strand 
RNA virus HEV, distantly related to alphaviruses, has been shown to bind Cin85 (Cbl 
interacting protein of 85 kDa), another SH3 domain protein that was detected also in 
our screen, through its protein ORF3 (open reading frame 3) (21). HEV pORF3 
localizes to recycling endosomes and delays the trafficking and degradation of 
epidermal growth factor receptor (EGFR) and hepatocyte growth factor receptor (c-
Met) (21). It is possible that alphavirus nsP3 functions in a similar manner as it 
segregates amphiphysin and other SH3 domain proteins including Cin85 into the 
replication complexes and nsP3 induced aggregates. This could help the virus to 
escape the host immune defences, by down scaling the signalling cascades needed for 
immune reaction. This could also explain why it would be beneficial for the virus to 
have stable nsP3 protein complexes aggregated in the cytoplasm, since these structures 
were detected to bind large amount of amphiphysin. 
Although amphiphysin-1 has been indicated in endocytosis, current data doesn’t 
support a similar role for amphiphysins in replication complex intake. First of all, 
amphiphysin-1 is expressed almost only in neuronal cells, but replication complexes 
are effectively internalized also in non-neuronal cells (III), (133). In contrast, 
amphiphysin-2 doesn’t function in endocytosis, but it may rather regulate recycling of 
cargo for exocytosis (115). Secondly, there was only a mild delay in CPV formation 
by Sh3BMd viruses, but no accumulation of replication complexes detected on the 
plasma membrane, as would be expected if amphiphysin binding by viral proteins 
would be crucial for internalization (III). This kind of accumulation at the plasma 
membrane has been seen with internalization deficient SFV 50 mutant (Fig. 8B) as 
well as with P13K inhibitors (157). 
Since amphiphysin binding has a considerable effect on viral RNA replication, it 
is tempting to speculate that amphiphysins might have a role in replication complex 
formation. As amphiphysins are membrane bending proteins, their role could be 
related to spherule formation. The BAR domain of amphiphysins can sense and induce 
membrane curvature with an outer radius of 11–15 nm (34). This could correspond to 
the curvature in the spherule neck. There are two sites in the spherule neck where the 
curvature could be favourable for amphiphysin binding (Fig.12). The curvature around 
the spherule neck is physically analogous to the binding site of amphiphysin-1 in 
endocytic vesicles, but it is difficult to imagine how amphiphysin could be located to 
this site, since spherules are formed in opposite direction compared to endocytic 
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vesicles, and are initially protruding outward from the plasma membrane (Fig. 2; 
fig.12). Another site where membrane curvature might be favourable for BAR domain 
is in the very beginning of the neck where positive curvature is formed on the inner 
side of the spherule (yellow dotted line in Fig. 12). 
The defect in recruitment of amphiphysin for spherule formation could explain 
the impaired RNA replication of amphiphysin binding deficient mutants. However, the 
binding deficient mutant viruses were viable, although replicating slowly and 
presented a weak colocalization between replication sites and amphiphysin (III). Thus 
it is possible that other factors in addition to nsP3 can drive the recruitment of 
amphiphysin. These factors could include other nsPs, viral RNA or host proteins that 
bind amphiphysin in a weak association that is not maintained in immunoprecipitation. 
It is possible that these indirect interactions would be able to recruit enough 
amphiphysin for a lower level of spherule formation. It is under a debate whether the 
function of amphiphysin in membrane morphogenesis is active induction of membrane 
bending or mere stabilization of preformed membrane curvature (67). If amphiphysin 
is not needed for induction of membrane curvature in spherule formation, BAR 
domains may be recruited to spherules independent of nsP3 binding, based on their 
affinity for extreme membrane curvature. However, amphiphysin binding through 
nsP3 would create a local concentration of amphiphysin and would thus promote 
formation of stable spherule structures. Another possibility is that amphiphysin is not 
directly needed replication complex formation, but the interaction between 
amphiphysin and viral replication is more complex and may include factors like 
reorganization of host cell pathways.  
 
Figure 12. Membrane curvature in alphavirus 
spherules. BAR domains sense positive curvature 
and preferably bind to sites of steep extreme 
membrane curvature with outer radius of 7-15 nm. 
In alphavirus spherule there are two sites with a 
curvature close to this radius. The spherule neck 
has been estimated to have radius of ~19-20 nm 
(depicted with red dotted line) (51). Steep positive 
curvature is also formed at site where spherule 
membrane protrudes outward from the cytoplasm 
(yellow dotted line). Potential BAR domain binding 
sites are depicted with red arrows. Cytoplasmic side 
is marked with “CYT”.  
 
In future, it would be interesting to examine the importance of amphiphysin 
binding through nsP3 in animal studies, to assess whether amphiphysin binding has a 
role in fighting the host immune defences and facilitating the viral pathogenesis. The 
role of amphiphysin-2 in viral RNA replication could be studied in more detail also by 
electron microscopy analysis of spherule formation to detect whether there are 
structural defects in spherules formed by amphiphysin binding incompetent viruses. 
Knockout/knockdown studies could be used to analyse whether amphiphysin has a 
CYT
60-70 nm
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direct role in RNA replication or whether replication defects are secondary effects 
resulting from reduced inhibition of host cell immune signalling. If amphiphysin-2 is 
needed for RNA replication, alphaviruses should not be capable of replicating in 
knockout cells, whereas if amphiphysin-2 recruitment is targeted to reduce host 
immune defence, knockout might be even beneficial to viruses and should not impair 
virus replication. 
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